Health‘Hopeful milestone’: Health Canada approves 2nd drug to slow Alzheimer’s – Nationalsys.adminMay 4, 2026 by sys.adminMay 4, 2026016 Health Canada has approved a second drug that can slow the progression of Alzheimer’s disease. Donanemab, sold by American drugmaker Eli Lilly under the brand...
